A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Recruiting · NCT07816185 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier) | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-11 | NCT07816185 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pulmovant, Inc. | 3 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||